2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).

2022 年 ESC 心脏肿瘤学指南与欧洲血液学协会 （ EHA ） 合作制定 ，欧洲治疗放射学和肿瘤学会 （ ESTRO ） 和国际心血管肿瘤学会 （ IC - OS ） 。

• 影响指数: 35.855
• 发表时间: 11 2022 1
• 来源期刊: Eur Heart J
• DOI: 10.1093/eurheartj/ehac244
• PMID: 36017568
• 文章类型: Journal Article
• 中科院分区: Q1
• 方向: 医学
• 作者列表: Lyon AR,López-Fernández T,Couch LS,Asteggiano R,Aznar MC,Bergler-Klein J,Boriani G,Cardinale D,Cordoba R,Cosyns B,Cutter DJ,de Azambuja E,de Boer RA,Dent SF,Farmakis D,Gevaert SA,Gorog DA,Herrmann J,Lenihan D,Moslehi J,Moura B,Salinger SS,Stephens R,Suter TM,Szmit S,Tamargo J,Thavendiranathan P,Tocchetti CG,van der Meer P,van der Pal HJH,

关键词: Amyloid light-chain cardiac amyloidosis; Androgen deprivation therapy; Anthracycline; Arrhythmias; Atrial fibrillation; Biomarkers; Cancer; Cancer survivors; Carcinoid syndrome; Cardiac magnetic resonance; Cardiac tumour; Cardio-oncology; Cardiotoxicity; Chemotherapy; Coronary artery disease; Echocardiography; Fluoropyrimidine; Guidelines; Haematopoietic stem cell transplantation; Heart failure; Hormone therapy; Hypertension; Immunotherapy; Ischaemic heart disease; Myocarditis; Pericardial disease; Proteasome inhibitors; Pulmonary hypertension; QTc prolongation; Radiotherapy; Risk stratification; Strain; Thrombosis; Trastuzumab; Valvular heart disease; Vascular endothelial growth factor inhibitors (VEGFi); Venous thromboembolism

Mesh: Humans; Radiation Oncology; Medical Oncology; Neoplasms / drug therapy; Heart; Hematology; Antineoplastic Agents / therapeutic use

Abstract

NUUL